Compound ID | 3103
Class: Glycopeptide
| Spectrum of activity: | Gram-positive |
| Details of activity: | Active against Staphylococcus aureus and Streptococcus haemolyticus; cell wall synthesis inhibitor |
| Description: | Natural product from Streptomyces platensis; shows necrotoxic properties on injection sites when administered via subcutaneous or intramuscular route; protects mice from Staphylococcus aureus infection |
| Institute where first reported: | Chugai Pharmaceutical Co., Ltd. |
| Year first mentioned: | 1975 |
| Development status: | Experimental |